MRI-guided focused ultrasound

In December 2024, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedures Guidance (Direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implant, MRI-guided focused ultrasound subthalamotomy and thalamotomy for treating Parkinson’s), one new Diagnostic Guidance (Home-testing devices for diagnosing OSAHS) and one new Early Value Assessment (Digital technologies to support self-management of COPD).

On May 6, 2024, the Swedish Medical Technologies Product (MTP) Council commissioned the Dental and Pharmaceutical Benefits Agency (TLV) to perform a health economic evaluation of MR-guided focused ultrasound (Exablate Neuro) for the treatment of patients with essential tremor and Parkinson's disease. This evaluation is a part of the Orderly introduction framework, a staged process aimed at managing the national introduction of novel technologies. Based on the TLV assessment, the MTP Council will make recommendations to regions regarding the implementation of the technology and the criteria for use.

In March 2024, several method assessments were initiated as a part of a framework for the managed introduction of innovations "New Methods" for cardiovascular, endocrine, gastrointestinal, men’s health, neurology and neurosurgery, neuromodulation, obstetrics and gynecology, robotic surgery, and some other fields.

On November 1, 2023, thirteen new procedure codes came into force in the updated Finnish classification of procedures (THL). The introduced codes concerned diagnostic imaging, radiology, neurology, peripheral vascular, and other fields.

The “New Methods” framework invited interested parties to submit information regarding magnetic resonance-guided high-intensity focused ultrasound (MRgFUS) for treating intracranial tumors, neurodegenerative disease, and pain related to bone metastases before October 31, 2023. Ordering Forum will then decide whether the method will undergo evaluation at the national level.

In September 2023, the Skåne University Hospital is working on several HTAs, including evaluations in the cardiovascular, diagnostic imaging, men’s health, neurology and neurosurgery fields

On July 17, 2022, the Austrian Institute for HTA (AIHTA) published four decision support documents, which provide recommendations regarding the inclusion of new medical interventions in the catalog of individual medical services of the performance-oriented hospital financing (Leistungsorientierten Krankenanstaltenfinanzierung, LKF) model, as well as three updates to previous decision support documents.

On July 3, 2023, the document "Changes and innovations in the 2024 LKF model" (Änderungen und Neuerungen in den LKF-Modellen 2024) was published. The document summarizes the most significant changes and innovations in the LKF model for inpatient and outpatient care. The newly added procedure codes mainly concern endoscopic procedures, orthopedics, peripheral vascular, and pulmonary and airways fields.

In March 2023, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced two more projects which received a subsidy under the "Subsidy scheme for promising care" in 2023 for research of focal therapy in intermediate risk prostate cancer and repetitive transcranial magnetic stimulation in paresis due to the cerebral infarction or cerebral hemorrhage.

In late September 2021, the Danish Health Data Agency (Sundhedsstyrelsen) has published the update of the Health Care Classification System (Sundheds-væsenets Klassifikations System, SKS). The most significant changes include: 31 new diagnosis codes and 14 procedure codes were added. The newly added procedure codes concern mainly pulmonary and airways area and neuromodulation procedures.

For the first time in three years, the Institute for Quality and Efficiency in Health Care (IQWiG) received data within the framework of the early benefit assessment of new examination and treatment methods (NUB) with high-risk medical devices according to §137h of Social Code Book (SGB) V. This involves seven invasive therapeutic cardiovascular, pulmonary, neurological, gastrointestinal, and urological procedures.

On January 07, 2021, NHS England published an update of the Specialized Services Policy Pipeline (covering the period October 19, 2020 - December 08, 2020). Two new Clinical Commissioning Policies were added to the work program, and six new policies related to radiotherapy, neurosurgery, pulmonology, and in-vitro diagnostics were published.